Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC

被引：5

作者：

Ricciuti, Biagio ^{[1
,2
]}

Garassino, Marina Chiara ^{[3
]}

机构：

[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02215 USA

[2] Harvard Med Sch, Dept Med, Boston, MA USA

[3] Univ Chicago, Med Ctr, Chicago, IL USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 06期

关键词：

LUNG ADENOCARCINOMA; MUTATIONS; OUTCOMES; KEAP1; TREMELIMUMAB; CHEMOTHERAPY; SENSITIVITY; CANCER; STK11;

D O I：

10.1016/j.jtho.2024.03.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：877 / 882

页数：6

共 32 条

[1] Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC [J].

Alessi, Joao V. ;

Elkrief, Arielle ;

Ricciuti, Biagio ;

Wang, Xinan ;

Cortellini, Alessio ;

Vaz, Victor R. ;

Lamberti, Giuseppe ;

Frias, Rosa L. ;

Venkatraman, Deepti ;

Fulgenzi, Claudia A. M. ;

Pecci, Federica ;

Recondo, Gonzalo ;

Di Federico, Alessandro ;

Barrichello, Adriana ;

Park, Hyesun ;

Nishino, Mizuki ;

Hambelton, Grace M. ;

Egger, Jacklynn V. ;

Ladanyi, Marc ;

Digumarthy, Subba ;

Johnson, Bruce E. ;

Christiani, David C. ;

Lin, Xihong ;

Gainor, Justin F. ;

Lin, Jessica J. ;

Pinato, David J. ;

Schoenfeld, Adam J. ;

Awad, Mark M. .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) :731-743

[2] Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer [J].

Arbour, Kathryn C. ;

Jordan, Emmett ;

Kim, Hyunjae Ryan ;

Dienstag, Jordan ;

Yu, Helena A. ;

Sanchez-Vega, Francisco ;

Lito, Piro ;

Berger, Michael ;

Solit, David B. ;

Hellmann, Matthew ;

Kris, Mark G. ;

Rudin, Charles M. ;

Ni, Ai ;

Arcila, Maria ;

Ladanyi, Marc ;

Riely, Gregory J. .

CLINICAL CANCER RESEARCH, 2018, 24 (02) :334-340

[3] Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer [J].

Bange, Erin ;

Marmarelis, Melina E. ;

Hwang, Wei-Ting ;

Yang, Yu-Xiao ;

Thompson, Jeffrey C. ;

Rosenbaum, Jason ;

Bauml, Joshua M. ;

Ciunci, Christine ;

Alley, Evan W. ;

Cohen, Roger B. ;

Langer, Corey J. ;

Carpenter, Erica ;

Aggarwal, Charu .

JCO PRECISION ONCOLOGY, 2019, 3 :1-11

[4]

Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]

[5] Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC) [J].

Chae, Young Kwang ;

Arya, Ayush ;

Iams, Wade ;

Cruz, Marcelo R. ;

Chandra, Sunandana ;

Choi, Jaehyuk ;

Giles, Francis .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6

[6]

David S, 2022, J NATL COMPR CANC NE, V5, P497, DOI DOI 10.6004/jnccn.2022.0025

[7] Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer A Systematic Review and Meta-analysis [J].

Duan, Jianchun ;

Cui, Longgang ;

Zhao, Xiaochen ;

Bai, Hua ;

Cai, Shangli ;

Wang, Guoqiang ;

Zhao, Zhengyi ;

Zhao, Jing ;

Chen, Shiqing ;

Song, Jia ;

Qi, Chuang ;

Wang, Qing ;

Huang, Mengli ;

Zhang, Yuzi ;

Huang, Depei ;

Bai, Yuezong ;

Sun, Feng ;

Lee, J. Jack ;

Wang, Zhijie ;

Wang, Jie .

JAMA ONCOLOGY, 2020, 6 (03) :375-384

[8] Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis [J].

Federico, Alessandro Di ;

Giglio, Andrea De ;

Gelsomino, Francesco ;

Sperandi, Francesca ;

Melotti, Barbara ;

Ardizzoni, Andrea .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (01) :29-42

[9] ClinicalandPathological Characteristics of KEAP1- and NFE2L2-Mutated Non-Small Cell Lung Carcinoma (NSCLC) [J].

Frank, Rieke ;

Scheffler, Matthias ;

Merkelbach-Bruse, Sabine ;

Ihle, Michaela A. ;

Kron, Anna ;

Rauer, Michael ;

Ueckeroth, Frank ;

Koenig, Katharina ;

Michels, Sebastian ;

Fischer, Rieke ;

Eisert, Anna ;

Fassunke, Jana ;

Heydt, Carina ;

Serke, Monika ;

Ko, Yon-Dschun ;

Gerigk, Ulrich ;

Geist, Thomas ;

Kaminsky, Britta ;

Heukamp, Lukas C. ;

Clement-Ziza, Mathieu ;

Buettner, Reinhard ;

Wolf, Juergen .

CLINICAL CANCER RESEARCH, 2018, 24 (13) :3087-3096

[10] Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [J].

Garassino, Marina C. ;

Gadgeel, Shirish ;

Novello, Silvia ;

Halmos, Balazs ;

Felip, Enriqueta ;

Speranza, Giovanna ;

Hui, Rina ;

Garon, Edward B. ;

Horinouchi, Hidehito ;

Sugawara, Shunichi ;

Rodriguez-Abreu, Delvys ;

Reck, Martin ;

Cristescu, Razvan ;

Aurora-Garg, Deepti ;

Loboda, Andrey ;

Lunceford, Jared ;

Kobie, Julie ;

Ayers, Mark ;

Piperdi, Bilal ;

Pietanza, M. Catherine ;

Paz-Ares, Luis .

JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (01)

← 1 2 3 4 →